Sample Size Calculations for Combination Drugs of 2 Monotherapies With a Single Approved Dose Level: Binary Endpoint Cases.
In this article, we study the sample size calculations for the combination drugs of 2 monotherapies with a single approved dose level when the primary endpoints are binary. Two study cases are examined: In the first, each monotherapy has the same indication, while in the second, each monotherapy has a different indication. The sample sizes are calculated by using an asymptotic joint distribution of test statistics and employing unequal allocation for 3 popular measures of 2 proportions: the risk difference, the log relative risk, and the log odds ratio. Results show that our proposed method produces smaller total sample sizes compared with the heuristic method. The total sample sizes can be reduced by incorporating unequal allocation and dependency between 2 test statistics.